TEER resolved recurrent cerebral infarction in a patient with degenerative mitral regurgitation despite a presumed contraindication of non-bacterial thrombotic endocarditis.
Does TEER resolve recurrent cerebral infarction in a patient with degenerative mitral regurgitation and non-bacterial thrombotic endocarditis?
TEER may be a viable option for resolving recurrent cerebral infarction in patients with degenerative mitral regurgitation and non-bacterial thrombotic endocarditis, despite it traditionally being considered a contraindication.
Tasa de eventos absoluta: 0% vs 0%
Degenerative mitral regurgitation (MR) is a common valvular heart disease, with transcatheter edge-to-edge repair (TEER) an alternative option for high-risk patients. Non-bacterial thrombotic endocarditis (NBTE), a rare condition with sterile valvular excrescences, often causes cerebrovascular embolism and is thought to be the contraindication to TEER.
Ma et al. (Wed,) reported a other. TEER resolved recurrent cerebral infarction in a patient with degenerative mitral regurgitation despite a presumed contraindication of non-bacterial thrombotic endocarditis.